In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ValveXchange Inc.

www.valvexchange.com

Latest From ValveXchange Inc.

Transcatheter Aortic Valves At The Five-Year Mark

Published data on transcatheter aortic valve implantation has reached the five-year mark and the outcomes suggest these devices may be as durable as many surgical valves, which is good news for this rapidly-growing market.

Medical Device

Transcatheter Valve Procedures Expected, Spurring Growth In Hybrid Operating Rooms

Infrastructure requirements for hospitals looking to expand their offerings to TAVR include a boatload of medical equipment. ECRI Institute discussed hospital considerations for offering transcatheter aortic valve implantation services in a recent webinar.

Medical Device Innovation

Deals Shaping the Medical Industry (09/2011)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

At PCR, Valves Steal The Show, But DES Shine

Every year for just about the past decade, drug-eluting stents dominated the agenda at the Paris Course on Revascularization and just about any meeting where interventional cardiologists gathered to hear the latest in technology and practice innovation. But without question, the star of this year’s PCR was percutaneous heart valves and, in particular the revolution in transaortic valve replacement that has been ushered in by Edwards Lifesciences., which acquired Percutaneous Valve Technologies several years ago, and Medtronic., as a result of its more recent CoreValve acquisition.
Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • ValveXchange Inc.
  • Senior Management
  • John Parrish, Chmn. & CEO
    Duane Knight, CFO
    Ivan Vesely, PhD, CSO
    Todd Campbell, Sr. Exec. Dir., Prod. Dev.
  • Contact Info
  • ValveXchange Inc.
    Phone: (303) 648-4077
    12635 East Montview Blvd.
    Aurora, CO 80010-7335
    USA
UsernamePublicRestriction

Register